[go: up one dir, main page]

DE60121817D1 - Blockade der natriumkanäle durch phenolderivate - Google Patents

Blockade der natriumkanäle durch phenolderivate

Info

Publication number
DE60121817D1
DE60121817D1 DE60121817T DE60121817T DE60121817D1 DE 60121817 D1 DE60121817 D1 DE 60121817D1 DE 60121817 T DE60121817 T DE 60121817T DE 60121817 T DE60121817 T DE 60121817T DE 60121817 D1 DE60121817 D1 DE 60121817D1
Authority
DE
Germany
Prior art keywords
alkyl group
halogen atom
sodium channels
hydrogen
blockade
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121817T
Other languages
English (en)
Other versions
DE60121817T2 (de
Inventor
Gertrud Haeseler
Martin Leuwer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Application granted granted Critical
Publication of DE60121817D1 publication Critical patent/DE60121817D1/de
Publication of DE60121817T2 publication Critical patent/DE60121817T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • A61K31/055Phenols the aromatic ring being substituted by halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DE60121817T 2000-11-15 2001-11-13 Blockade der natriumkanäle durch phenolderivate Expired - Lifetime DE60121817T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00124870A EP1206934A1 (de) 2000-11-15 2000-11-15 Blockade von Natriumkanälen mit Phenolderivaten
EP00124870 2000-11-15
PCT/EP2001/013081 WO2002040005A2 (en) 2000-11-15 2001-11-13 Blockade of sodium channels by phenol derivatives

Publications (2)

Publication Number Publication Date
DE60121817D1 true DE60121817D1 (de) 2006-09-07
DE60121817T2 DE60121817T2 (de) 2007-08-02

Family

ID=8170379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121817T Expired - Lifetime DE60121817T2 (de) 2000-11-15 2001-11-13 Blockade der natriumkanäle durch phenolderivate

Country Status (6)

Country Link
US (1) US7485669B2 (de)
EP (2) EP1206934A1 (de)
AT (1) ATE333870T1 (de)
DE (1) DE60121817T2 (de)
ES (1) ES2264453T3 (de)
WO (1) WO2002040005A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6254681B2 (ja) 2013-05-09 2017-12-27 スーチュアン ハイスーク ファーマシューティカル カンパニー リミテッド フェノール誘導体及びその製造方法及び医薬的な応用
WO2017211307A1 (zh) * 2016-06-08 2017-12-14 四川海思科制药有限公司 苯环衍生物及其制备方法和在医药上的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1924169A (en) * 1931-03-10 1933-08-29 Otis Clapp & Son Inc Antiseptic preparation
IL71864A (en) * 1984-05-17 1984-11-30 Haviva Rivkin Lotion for blemished skin comprising thymol
SK147995A3 (en) * 1993-06-03 1997-04-09 Univ Sydney Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
US5730965A (en) * 1996-06-13 1998-03-24 Dermatology Home Products, Inc. Shampoo for treating seborrheic dermatitis, dandruff or psoriasis
US5837270A (en) * 1996-08-26 1998-11-17 Burgess; Nelson Leon Topical anti-acne composition
US5827523A (en) * 1997-04-29 1998-10-27 Holland; Dennis A. Universal topical antiseptic first aid spray
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents

Also Published As

Publication number Publication date
WO2002040005A3 (en) 2003-08-28
US20040044084A1 (en) 2004-03-04
EP1357906B1 (de) 2006-07-26
WO2002040005A2 (en) 2002-05-23
ATE333870T1 (de) 2006-08-15
DE60121817T2 (de) 2007-08-02
ES2264453T3 (es) 2007-01-01
EP1206934A1 (de) 2002-05-22
US7485669B2 (en) 2009-02-03
EP1357906A2 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
NO20092832L (no) Fremgangsmate for karbonylering av en forbindelse
MX9206740A (es) Derivados aromaticos de amino-alcohol que tienen propiedades antidiabeticas y antiobesidad, su preparacion y sus usos terapeuticos.
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
DE69530094T2 (de) Thiazolidindione derivate, ihre herstellung und verwendung
DE69505968D1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
DE69316068D1 (de) 1-[2-(Arylsulfonylamino)-1-oxoethyl]piperidin-Derivate, ihre Herstellung und therapeutische Verwendung
BR1100636A (pt) Agente terapêutico para o mal de parkinson, e, derivado da xantina
DE60020246D1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
DE69412016D1 (de) Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
PT1257552E (pt) Derivados de xantina, intermediarios e aplicacao ao tratamento de osteoporose
DE60121817D1 (de) Blockade der natriumkanäle durch phenolderivate
DK0835251T3 (da) Fremgangsmåde til fremstilling af liponsyre
DE69023939D1 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
DE60013560D1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
CA2225780A1 (fr) Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE187169T1 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
NO921282D0 (no) Benzotiazolderivater og deres anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition